List of Biotech, Pharmaceutical & Life Sciences companies in Missouri - 45

Addison Biological Laboratory, Inc. is a Fayette, MO based manufacturer and marketer of exclusive veterinary technologies. For over a third of a century, J. Bruce Addison, president and founder, has been recognized as a leader in veterinary diagnostics and herd specific bacterin production. The reputable MAXI/GUARD® product line is best known for its M. bovis (pinkeye) cattle bacterin among bovine veterinarians and Nasal Vac (intranasal respiratory) baby pig vaccine among swine practitioners. Both technologies are recognized as efficacy leaders and privately labeled for large multinational biological manufacturer/marketers. Companion animal product offerings in veterinary dental home care, dermatology, otology, and wound care provide medical researched technologies that define today’s zinc-based product standards. Marketing accomplishments include a successful export history to over 25 countries and recognition as Missouri’s Exporter of the Year. The U.S. Chamber of Commerce selected Addison Biological Laboratory, Inc. as the recipient for its prestigious Regional Blue Chip Enterprise Initiative Award. “Our mission is to be the premier provider of exclusive and innovative technologies to assist the global betterment of animal care by solving problems for veterinary professionals, animal producers, and pet owners.”

Agragene has developed Precision-Guided Sterile Insect Technology that will reduce grower's reliance on the 6 billion pounds of pesticides used on crops each year. Agragene is ready to deploy its first "Knock-Out" product in the field which targets spotted wing drosophila. The "Knock-Out" product will benefit crop growers in 3 key ways. 1) The product is much cheaper than the chemical pesticides used now, 2) scarce and expensive field labor is not required and 3) the resulting pesticide-free crop can be Organic-approved which increases grower's profits. Importantly, "Knock-Out" is non-toxic to bees, other beneficial organisms, the environment and humans. With many states and countries banning pesticides growers must look to safer and cheaper alternatives. Agragene has the solution.

AgriGro’s® formulations deliver plant nutrition along with a prebiotic concentrate, which significantly increases the growth of beneficial native microbial species. The company sells prebiotics for crops, livestock, gardening, golf, and wildlife. The company also makes a prebiotic formulation for treating organic waste or bio-solid residue.

Allied Healthcare Products, Inc. is a leading manufacturer of medical gas construction equipment, respiratory therapy equipment, home healthcare products, and emergency medical supplies. Our products appear worldwide in a range of medical applications, including hospital care, sub-acute treatment, long-term care, home healthcare, and medical emergencies. Allied Healthcare Products, Inc. is a U.S. manufacturer of FDA approved respiratory medical devices and immobilization products with over 60 years of experience in the industry. Our products are produced in an ISO13485:2016 facility and we carry the capability to apply the CE mark to the products we produce. Allied manufactures transport ventilators, airway products, and immobilization devices under the Life Support Products (LSP) brand. For more information, please visit www.alliedhpi.com or www.ahp300.com.

For more than 160 years, Anheuser-Busch has been woven into the cultural fabric of the United States, carrying on a legacy of brewing great-tasting, high-quality beers that have satisfied beer drinkers for generations. Today, we own and operate more than 120 facilities and have more than 19,000 colleagues across the United States. We are home to several of America’s most recognizable beer brands, including Budweiser, Bud Light, Michelob ULTRA and Stella Artois, as well as a number of regional brands that provide beer drinkers with a choice of the best-tasting craft beers in the industry. From responsible drinking and emergency drinking water programs to industry-leading sustainability efforts, we are guided by our unwavering commitment to supporting the communities we call home. We are a company that believes our people are our greatest asset. We believe in the spirit of ownership because our employees take results personally and want to build something great together. We value talented employees who aren’t afraid to be bold, resourceful, and committed. At Anheuser-Busch, it’s not about what you studied or where you worked, it’s about what you can do. If you see yourself working for a company that allows you to excel at the pace of your talent, then a career at Anheuser-Busch may be for you. As America’s leading brewer, we are committed to finding innovative ways to continually improve. It's this kind of thinking that creates a unique work environment by rewarding talent, celebrating diversity and encouraging forward thinking. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status or any other characteristic protected by applicable law. For more information, visit www.anheuser-busch.com/careers.

Antibody Research Corporation is a biotechnology company that specializes in offering custom antibody and protein services including monoclonal and polyclonal antibody development, gene cloning, in vitro antibody production, cell line engineering, and assay development.

Biologics

OUR COMPANY BioMed Valley Discoveries, Inc., is a clinical stage biotechnology company with a mission to address unmet patient needs across a wide spectrum of diseases. Operating since 2007, BioMed Valley Discoveries advances its mission with commercial capabilities and resources typically unavailable to academic institutions. As a member of the Stowers Group of Companies, our stable long-term funding allows us to advance programs that may not fit within the model of more traditional clinical development groups. OUR APPROACH BioMed Valley Discoveries leverage several hundred experts at leading academic and clinical institutions to move projects forward in the early stages of clinical development. Our partners have a proven track record of scientific rigor and experience in efficient study execution. Our selection of development partners is based on our desire to address unmet patient needs and achieve critical development milestones as swiftly as possible. Through this approach, we endeavor to quickly answer scientific questions and determine next steps in the development process. OUR TEAM BioMed Valley Discoveries calls on the talents of a core leadership team of scientists who are focused, passionate, and committed to advancing new medical innovations to improve the lives of patients with difficult-to-treat diseases. Our team brings extensive experience from pharma, biotech, and academia. By utilizing unique advantages from each of these settings, BioMed Valley Discoveries creates a highly creative and functional drug development environment. We take a nimble and thoughtful approach to advancing programs with a focused sense of urgency, allowing for the most efficient path forward.

C2N Diagnostics is a molecular diagnostics company aiming to transform the early diagnosis and early treatment of Alzheimer's disease and related forms of dementia. They are developing and accelerating novel diagnostics and therapies for Alzheimer's disease, including the new PrecivityAD™ blood test for Alzheimer's disease.

Canopy Biosciences, a Bruker company, empowers innovation by providing access to cutting-edge spatial biology and multi-omic tools so biomedical researchers can drive scientific discovery faster. Our proprietary technology ChipCytometry™ is a quantitative multiplex immunofluorescence imaging method for the spatial analysis of complex tissues and mapping of cell populations with single-cell resolution. Supported by Canopy Spatial Services™ with our CLIA-certified laboratory, we provide a unique collection of spatial and single-cell technologies that accelerate the understanding of cellular diversity and interaction. Learn more at CanopyBiosciences.com.

Certus International is an integrated Contract Research Organization and Imaging Core Lab Service Company offering a full range of clinical trial management, consulting and imaging services. Certus, founded in 1995, is a company whose goal is to be accessible, reliable and transparent for its clients. We do this, in part, by being flexible, maintaining a flat organizational structure, having a real person answer the phone when you call and constantly improving customer service, no matter how good you think it is. We also strive to maintain an excellent working relationship with the FDA. Every clinical trial we partner on is customized per the sponsor's requested needs and our suggestions based on the experience that hundreds of trials and over 28 years have given us.

Children's Mercy Hospital is a 367-bed comprehensive pediatric medical center in Kansas City, Missouri that integrates clinical care, research and medical education to provide care for patients ages birth to 21.

Elemental Enzymes Ag and Turf, is a life sciences company that discovers, develops and produces innovative products to increase crop yields. Elemental Enzymes was founded in 2011 on technology to make and stabilize novel enzymes and has grown to address the agriculture market with enzyme and chemical technologies that have an "outside in" approach to address crop needs. Elemental Enzymes is delivering world class products to top agricultural companies through license and sales opportunities. Elemental Enzymes is always looking for energetic, challenge driven staff to continue support of current products and lead its' innovative pipeline to market.

Engineered Tissue Solutions (ETS) is an emerging wound care company, re-defining wound care with cutting-edge bioactive glass technology that reduces healing time, minimizes treatment costs and improves patient outcomes. Our flagship product, MIRRAGEN® Advanced Wound Matrix, is a next-generation intervention for wound healing. Using synthetic, absorbable bioactive glass fiber technology, MIRRAGEN accelerates healing, decreases wound area, reduces costs, and is safe and easy to use.

Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics. Geneoscopy's lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designation from the FDA for its ability to reduce morbidity associated with colorectal cancer through advanced adenoma detection. Our initial prospective clinical study demonstrates that the diagnostic can detect these lesions with greater sensitivity than all existing noninvasive screening tests, thereby, serve as a potential aid in early detection and prevention of cancer. Geneoscopy is also developing diagnostics for the diagnosis and management of inflammatory bowel disease in partnership with biopharmaceutical companies and leading academic research institutions.

Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate polymer IP-001 for the treatment of solid tumor cancers. IP-001 has unique physio-chemical and immunological properties that allows it to ignite a systemically active cancer immunotherapy from a routine tumor ablation; a minimal invasive intervention that destroys tumors and in doing so liberates tumor antigens. IP-001 enhances interactions of tumor antigens with the immune system, improves the motility of tumor infiltrating T cells, promotes their surveillance of tumor tissue and can generate long-term protective immunity.

We make tools that transform preanalytical workflows, to detect threats, explore microbiomes, or enable discoveries, faster, easier, and better. InnovaPrep specializes in the development and manufacture of preanalytical solutions designed for rapid collection and concentration of nano and microorganisms, as well as biological and synthetic particles from various sources such as air, liquids, and surfaces. Central to InnovaPrep's innovation are over 60 patents awarded and pending, centered on a novel Wet Foam Elution™ process, enabling robust and rapid particle concentration, thereby significantly enhancing detection capabilities, simplifying workflows, and reducing time to result.

Integro Theranostics is a clinical stage company developing fluorescent imaging agents and associated medical devices that enable surgeons to readily see and remove cancerous tissue. This accurate, real-time visualization of cancer tissue facilitates a more complete removal of cancer during surgery. Integro Theranostics was born out of a collaboration between Kingdom Capital (values based private investment company) and Washington University School of Medicine. We are combining the clinical infrastructure of a top research medical center, the technology of a world renowned scientist, and the resources of Kingdom Capital to commercialize this transformative technology and improve surgical outcomes for cancer patients.

Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company's best-in-class product offerings include Arteriocyte's market-leading Magellan® Autologous Platelet Separator and Isto's bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; and Influx™, a natural bone-graft material.

For scientists in life sciences discovery, and biopharmaceutical and diagnostics segments utilizing antibodies, biologically active proteins, and assays, reproducible science is the key to unlocking the scientific doors. Leinco Technologies Inc. adheres to ISO 9001:2015 and ISO 13485:2016 quality standards, and provides access to antibodies and proteins used in a broad range of life sciences applications uncovering interactions in cancer, infectious diseases and immunology. Our proprietary techniques result in the highest purity antibodies (monoclonal, recombinant and polyclonal) and proteins enabling scientists globally to generate reproducible science and faster time to scientific results across a broad range of cell, tissue and in vivo applications (e.g. spatial biology, flow cytometry, pre-clinical in vivo and in vitro studies). For our many partners, the Leinco scientists with over 30 years’ experience take a consultative approach and are committed to delivering the highest quality CDMO services (e.g. antibody scale-up and purification, optimized conjugation to reporter molecules and assay development/manufacturing) that save time and ensure our customers are successful in their programs.

Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to degradable coatings that deliver cells over days, weeks, or months, we can create exclusive hydrogel formulations tailored for each therapeutic application. Likarda is the remarkable culmination of visionary leadership, science that is just as artistic as academic, and a compelling urge to do what’s right. As we move forward, we have well-defined, long-range goals with added opportunities for flexibility and growth.

Maximum Fidelity Surgical Simulations provides hyper-realistic surgical and trauma simulations for surgeons, forward field operators, medics, and medical device development. They meticulously customize each simulation to meet the unique educational, research, or business needs of their clients.

Mayflower Bioscience is an experienced, specialist life science distributor in the USA. Headquartered in St. Louis, we identify and commercialize unique products for biological research, drug discovery and bioproduction for emerging life science companies. Areas of product focus include Regenerative and Degenerative Medicine, Biomarkers, Cell Biology and Molecular Biology.

At Mediomics, we strive to help scientists and researchers discover new drugs. We are an innovative life sciences company specializing in homogeneous assay kits. Our goal is to make the lives of scientists and researchers easier. Our focus is quick and easy assay kits, high affinity binding reagents, and biosensors for detecting biologically and therapeutically important macromolecules, biomarkers, and pathogens. These kits are valuable resources for scientists in the pharmaceutical, biopharmaceutical, and biotechnology industries, as well as university, hospital, and national laboratory researchers. Our platform Bridge-It, FRET-PINCER, and TRF-PINCER technologies have already been adapted for the detection of a range of important macromolecules, including cAMP, tryptophan, S-adenosyl methionine, PDE, biotin, insulin, C-peptide, albumin, C-reactive protein (hCRP), IgG, IgM, E. coli, and others.

MRIGlobal is a world leader in applied science and technology research. We work with government agencies, commercial businesses, and academic institutions to provide independent research and innovative development. We are trusted partners steeped in technical excellence and a personal connection with each client. Contact us to learn how we can help you solve your program needs. We look forward to getting to know you.

Thanks for visiting our profile. We'd love for you to join our outstanding team working to enhance Missouri's natural resources. Our Mission: The Missouri Department of Natural Resources protects our air, land, water, and mineral resources; preserves our unique natural and historic places; and provides recreational and learning opportunities; while promoting the environmentally sound and energy-efficient operations of businesses, communities, agriculture, and industry for the benefit of all Missourians. Social Media Moderation Policy: https://dnr.mo.gov/communications/connect-social-media/moderation-policy

Overview: To provide “best in class” genomic services for supporting our partner’s R&D capabilities solutions in the agriculture (plant and animal), pharmaceutical and industrial biotech industries. Experience: MOgene was formed in 2004, by industry leaders in genomic research. Over the years, the experienced team at MOgene have established themselves a solid reputation within the industry as the “go to” genomics service provider for academic, government and industrial research groups and institutions. Multiple studies have been presented and published in leading scientific journals, based on the genomic services provided by MOgene. Providing Results: The scientists at MOgene have years of experience collaborating with scientists in multiple biotech industries to provide solutions for their research. There have been over 100 publications from both large and small research companies utilizing data from MOgene services. Specialties: PacBio Sequel, Illumina Next Gen Sequencing, MicroArrays, QuantiGene and ProCarta Multiplex Assays, Nucleic Acid Extraction, qPCR, Clinical assays utilizing Arrays and NGS, plus full bioinformatics capabilities.

At NewLeaf Symbiotics, they believe naturally occurring microbes called M-trophs have the potential to revolutionize the world’s approach to sustainable agriculture.The first breakthrough in this new class of ag biologicals is called Terrasym. Terrasym products contain specially selected living M-trophs and can be applied in-furrow, on seed, or as foliar sprays. Terrasym products establish a natural, permanent partnership with plants. This symbiotic relationship makes crops stronger, more stable, and more tolerant of stress throughout their life cycle.

Omniose was founded in 2016 based on the pioneering glycoconjugation discoveries of our scientific founders Mario Feldman and Christian Harding through a scientific collaboration that characterized a new class of conjugating enzymes. The research operations were established at BioGenerator Labs in St. Louis and the company was previously known as VaxNewMo. Omniose has been awarded $11.2 million in grants from the US NIAID for use of our platform technology to develop vaccines against Group B Streptococcus, Klebsiella pneumoniae, and Streptococcus pneumoniae. Omniose announced an expansion of the team in April 2022 with the addition of Timothy Cooke as CEO and Roman Fleck as Chairperson. Both of these highly experienced executives are based in the Boston area. The company also announced the formation of a Scientific Advisory Board with co-founder Mario Feldman and Steven Projan, who brings deep industry experience in infectious disease drug and vaccine development.

OpenCell Technologies™ is a leading innovative company developing a cutting-edge, continuous, scalable, non-viral, cell agnostic soft-poration transfection technology. Our breakthrough platform enables efficient continuous delivery of large cargos into challenging cell types, expanding the frontiers of cell engineering in Biopharma and Cell & Gene Therapy. With precise control at the single-cell level and high throughput, our OpenCell™ technology drives scientific discovery and enhances the effectiveness, affordability, and scalability of current cellular therapies. We empower researchers and clinicians to achieve remarkable advancements in biomedical science and clinical practice.

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports. Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems. We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic's SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.

We're PercayAI, an AI venture providing fundamentally different augmented intelligence software across a variety of healthcare applications, including a variety of healthcare applications, including life sciences, drug discovery, payment integrity, and medical claims. Founded in 2019, PercayAI is made up of an interdisciplinary team with expertise across life sciences, technology and enterprise business who think differently about technology and its impact on our life.

Plastomics' novel trait delivery technology harnesses the power of the plant cell to create crops than can better withstand the pressure of insects, diseases and weeds and that are more efficient and deliver higher yields. Plastomics technology will give seed companies the benefits of simplified product development, more effective products and new market opportunities.

Many solutions to global threats such as climate change, disease and crop infestation can be found right beneath our feet. Microbes in the soil have proven potential to sequester carbon, improve crops, kill pests, reduce disease and more. Pluton Biosciences utilizes unique Micromining™ technology to discover novel microbes and create innovative solutions to address key sustainability challenges facing agriculture.

When you replace traditional leather chemicals with probiotic biochemicals, you lower costs and create a safer, more sustainable leather-making process.

Currently, SafetyFix is the one and only FDA approved removable bone screw on the market with patents in the US, Europe, Canada, China, & Australia. The SafetyFix EasyOut Removable Bone Screw can be used for bone fracture repair and other surgical procedures involving the foot, hand, wrist, ankle, elbow and other small bone corrective procedures. We believe no one should live with metal hardware in their body, which is why we have created the solution.

Formed in 2012 Sequoia Vaccines, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of a novel vaccine to prevent bacterial infections, including recurrent urinary tract infections (UTIs) and the treatment of certain cancers and lung infections associated with cystic fibrosis with small molecules.

SpineSource is commencing the U.S. launch of the CATAMARAN™ SIJ Fusion System, patented and manufactured by Tenon Medical, Inc. (Los Gatos, CA). The titanium CATAMARAN™ SIJ engages the ilium and sacrum via a posteroinferior approach with two fenestrated pontoons joined by an osteotome bridge spanning the joint.  It's pontoons and bridge are packed with autograft harvested off the drill bit used to prepare the joint. Just one implant is required. This posteroinferior approach targets the dense aspect of the joint. It's entry point, angle and trajectory point away from critical neural and vascular structures. The Mission of SpineSource is to provide implant devices, service and expertise using the highest ethical standards to benefit hospitals and surgeons, assisting them to promote the healing and well-being of patients with spinal disorders.

Pioneering Endovascular Robotics | Global leader in robotic technologies to enhance the treatment of arrhythmias & perform endovascular procedures

Established in 1962, St. Louis Community College is the largest higher educational institution in the region and the second largest in Missouri. STLCC has served more than 1.2 million students; at least one person in more than one-half of the households in the St. Louis area has attended the College.

Trially is the first AI-native clinical trial enrollment platform that matches, engages and enrolls patients at breakthrough speed and ~95% accuracy. Loved by customers, Trially LLM agents fill trials faster—with 2-6x increase in enrollment rate, 73% fewer screen fails, and 91% less prescreening time. Trially’s site-based software rapidly prescreens patients from any clinical data source, fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001. Designed to meet the needs of Physicians, Sites, Sponsors and CROs, Trially AI empowers you to achieve outstanding results in clinical research.

NOVUS is a global leader in health and nutrition solutions for the animal agriculture industry. Customers worldwide trust NOVUS products as an integral part of their daily animal agricultural operations. Connect with us at: www.novusint.com www.facebook.com/novusint www.youtube.com/novusinternational Social Media For Public Usage and User Generated Content Policy http://www.novusint.com/pages/socialmediaforpublicusageandusergeneratedcontentpolicy

Washington University in St. Louis is a university that focuses on providing higher education and conducting research.

Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies. Wugen is based out of St. Louis, Missouri and San Diego, California.